Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Multiple Sclerosis Research

Multiple sclerosis is a neurological disorder affecting the central nervous system and thus causing impairment in most of the physical, mental and behavioural condition. “Results of key natural history of studies from carefully managed data sets have unfortunately lead some leading experts in the field of multiple sclerosis to conclude that the most severe cases of multiple sclerosis are causally connected to degenerative processes as the primary driver of disability” The Clinical Course of Multiple Sclerosis Needs to be Redefined in the Treatment Era of MS, Scott TF. The management of this disease involves different therapeutic options. These treatment modalities include different approaches such as diet, drug treatment methods, physiotherapy and disease management as well as other alternative therapies. “During the last two decades, accumulating experimental and clinical evidence suggested that hematopoietic stem cell transplantation (HSCT) might be used for the treatment of aggressive Multiple Sclerosis (MS), unresponsive to conventional immunomodulatory and immunosuppressive agents” Stem Cell-based Therapies in Multiple Sclerosis Kimiskidis VK, Fassas A. This journal deals with recent advancements in multiple sclerosis and associated research. The complementary and alternative therapies in this field of research are major topics of interest to our journal. Since drugs are not the ultimate remedy for this disease there are so many other therapeutic strategies and treatment modalities in this area. Journal explores various researches in this field and thus brings them out through our articles.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on September, 2024

Top